Carregant...
Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
BACKGROUND: There is no consistent evidence about the appropriate treatment strategies for gastric signet ring cell carcinoma (GSRC) to improve prognosis. We conducted a population‐based study to examine the effects of combined modality therapies on survival outcomes using the Surveillance, Epidemio...
Guardat en:
| Publicat a: | Cancer Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520351/ https://ncbi.nlm.nih.gov/pubmed/32744431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3342 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|